SISergey E Ivannikov

Sergey E Ivannikov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergey E Ivannikov has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • POSSIBILITIES FOR PREDICTING COURSE AND PROGRESSION OF EARLY-ONSET PREECLAMPSIA

    by T. I. Isaev, L. D. Belotserkovtseva, L. V. Kovalenko, S. E. Ivannikov, V. N. Zinin

    Preeclampsia is a disease that complicates pregnancy and the postpartum period. Characterized by multiple organ dysfunction syndrome (MODS) and associated with endothelial dysfunction, preeclampsia represents a major maternal mortality factor. Timely preeclampsia diagnosis and prediction of the condition’s progression constitute a complex and topical issue. Researchers attribute this to the fact that existing laboratory methods lack preferable accuracy and widespread application. To promptly predict the early-onset severe preeclampsia development and progression of the disease’s mild form, the authors suggest identifying both the optimal and available combination of MODS biochemical markers. The article reviews the scientific materials on the subject published in PubMed, eLIBRARY.RU, and CyberLeninka databases over the past 10 years. The studies on early-onset mild and severe preeclampsia, methods for predicting the condition, and the risk of early-onset mild preeclampsia progression are examined.

  • EFFICACY COMPARISON OF COMBINED AND ORAL IRON THERAPY FOR IRON DEFICIENCY ANEMIA IN PREGNANT WOMEN

    by L. D. Belotserkovtseva, V. N. Zinin, S. E. Ivannikov, M. R. Keldasova

    Iron deficiency anemia (IDA) remains one of the most relevant medical and social issues globally. The article aims to compare the effect of combined iron therapy and monotherapy via oral iron drugs on the pregnancy course, labor, and neonatal outcomes in women with IDA. Involving 149 pregnant women with the specified pathology, the authors carried out a prospective study. The examined were divided into 2 groups: the main group (n = 121) was treated using combined therapy (oral and parenteral iron medications); the control group (n = 28) received oral therapy only. The paper evaluates the groups’ peculiarities in the pregnancy course, labor outcomes, neonate medical condition, including cord blood ferritin and hemoglobin. The research reveals that combined therapy reduces the incidence of urinary tract infections (5.8% versus 21.4%, p < 0.05) and premature rupture of membranes (7.4% versus 21.4%, p < 0.05). In contrast, oral therapy increases the risk of postpartum hemorrhage (14.3% versus 5%, p = 0.093) with the subsequent need for blood transfusion (25.0% versus 3.3%, p < 0.001) and parenteral iron therapy for IDA (10.7% versus 1.7%, p = 0.046). The combined therapy efficacy is confirmed by the following laboratory values: a higher Hb level in the antepartum and postpartum period (p < 0.001). The absence of statistically notable differences in hemoglobin (159.4 versus 156.2 g/L, p = 0.394) and ferritin (104.3 versus 186.0 μg/L, p = 0.108) levels in umbilical cord blood between the studied groups indicates that combined therapy does not significantly improve neonatal iron status. Further studies evaluating long-term neurological outcomes are needed to determine the effect of iron therapy on postnatal development.

  • Predictors of the need for insulin therapy in gestational diabetes mellitus and the relationship between the need for insulin and the condition of newborns

    by L.D. Belotserkovtseva, L.V. Kovalenko, S.E. Ivannikov, E.N. Yerchenko

    Objective. To determine the factors influencing the need for insulin therapy in gestational diabetes mellitus (GDM), and to compare perinatal outcomes in groups of patients receiving diet therapy and insulin therapy. Materials and methods. A retrospective study of 308 cases of pregnancies complicated by GDM was conducted, depending on the GDM therapy used in late premature and term delivery. Group 1 included 277 pregnant women who were prescribed diet therapy, group 2 included 31 pregnant women who received insulin therapy. Results. The patients of the 2nd group were obese 2 times more often than the patients of the 1st group. In group 2, GDM was diagnosed before 24 weeks of pregnancy in 22.6% of cases, and in group 1 — in 8.7%. Hypertensive disorders during pregnancy in group 2 were diagnosed 4 times more often than in group 1: in 13 (41.9%) and 27 (9.7%) women, respectively. The birth rate of children large for the corresponding gestational age (over the 90th percentile) in women in labor with GDM was 16.6%, among them 44 (15.9%) were born in patients of the 1st group and 7 (22.6%) — in women of the 2nd group. Asphyxia of moderate severity at birth was found only in the 2nd group in 1 child (3.2%). Intrauterine hypoxia, first noted during childbirth, was diagnosed in 9 (3.2%) children in group 1 and in 1 (3.2%) child in group 2. Newborns in group 2 needed respiratory support more often: 2 (0.7%) in group 1 and 2 (6.5%) in group 2. Conclusion. The need for insulin therapy increases in pregnant women with an early diagnosis of GDM (up to 24 weeks of pregnancy) and with the presence of obesity. In the group of patients who required insulin therapy, hypertensive disorders were more often detected during pregnancy, the frequency of perinatal asphyxia and respiratory support for newborns increased.

  • Early preeclampsia: features of clinical presentation, diagnosis, treatment, and maternal–neonatal outcomes

    by T. I. Isaev, L. D. Belotserkovtseva, L. V. Kovalenko, S. E. Ivannikov, V. N. Zinin

    The aim of the research is to study the features of manifestation and outcomes of childbirth in early development of preeclampsia in singleton pregnancies. The retrospective analysis included 150 pregnant women diagnosed with early preeclampsia manifested at 34 weeks + 0 days for the period 2017–2019. The average age of pregnant women was 31 years (26–35) (Me, Q1–Q3), of which 81 (53,64%) were repeat births. The median gestation period at which clinical manifestations occurred was 31,4 weeks. The most common primary clinical symptom was edema 142 (94,7%). At the time of the manifestation, 122 (81,3%) moderate and 28 (18,67%) severe early preeclampsia were detected. Of 123 observations, moderate early preeclampsia in 31 (20,67%) cases progressed to severe. Thus, in 39,33% of cases, the early preeclampsia reaches a severe degree. The majority of patients required an early 32,4 weeks (30,4–34,0) surgical delivery. Nosologies based on endothelial dysfunction were common: 30 (19,9%) chronic arterial hypertension and 19 (12,6%) type 2 diabetes mellitus cases. The frequency of premature detachment of the normally located placenta was 10 (6,67%) cases. The average hospital stay for children was 33 (23–48) days. A high frequency of adverse outcomes for newborns with early preeclampsia was revealed. 7 children died antenatally (46,7%), of which 4 were associated with premature detachment of the normally located placenta, 2 children died on 55 and 93 days of life.

  • The features of the pregnancy in women with term delivery and iron deficiency anemia of varying severity

    by Surgut district clinical center for maternity and childhood health, L. D. Belotserkovtseva, Surgut State University, L. V. Kovalenko, V. N. Zinin, S. E. Ivannikov, Surgut district clinical center for maternity and childhood health; Surgut State University, M. R. Keldasova

    Iron deficiency anemia (IDA) affects up to 40% of pregnant women. Purpose of the study – to evaluate the impact of varying IDA severity on pregnancy and delivery terminations and neonatal status at term delivery. A retrospective study was conducted involving 263 pregnant women who delivered at term. Based on hemoglobin (Hb) levels in the third trimester, patients were divided into three groups: Group 1 – mild IDA (n=217), Group 2 – moderate IDA (n=43), and Group 3 – severe IDA (n=10). Pregnancy course, method of delivery, and neonatal status were compared. Significant differences in Hb levels were observed between the groups throughout pregnancy (p<0.001). In severe IDA, the incidence of hypertensive disorders (30% vs 5.5%, p=0.010) and oligohydramnios (50% vs 4.1%, p<0.001) was higher compared to mild IDA, and the incidence of chorioamnionitis was 10 times higher compared to other groups (p=0.005). With increasing IDA severity, neonatal birth weight significantly decreased (Group 1=3430 g, Group 2=3250 g, Group 3=3270 g; p<0.001). Women with severe IDA required parenteral iron therapy 30 times more often (33.3% vs 0.5%, p<0.001) and blood transfusion 25 times more often (70% vs 2.8%, p<0.001) than those with mild IDA. The results demonstrate that increasing severity of IDA is associated with a higher incidence of hypertensive disorders, oligohydramnios, infectious complications, reduced neonatal birth weight, and a significantly increased need for parenteral iron therapy and blood transfusion.

  • Changes in management tactics and treatment outcomes of patients with isthmic-cervical insufficiency in the second decade of the 21st century based on the results of research at the Surgut District Clinical Centre for Maternal and Child Health Care

    by L.D. Belotserkovtseva, S.E. Ivannikov, G.T. Mirzoeva, A.V. Parfenova

    OBJECTIVE To improve the course and outcomes of pregnancy in patients with isthmic-cervical insufficiency (ICI) by optimizing the management tactics. MATERIAL AND METHODS An open, retrospective, observational, comparative study was conducted. Pregnant women who received inpatient treatment for ICI were divided into 2 groups: pregnancy and delivery in 2011 (group 1, n=110) and in 2019 (group 2, n=138). Exclusion criteria: congenital malformations, multiples, no data of pregnancy outcome. The course of pregnancy and peculiarities of delivery were analyzed. RESULTS Pregnant women of both groups had a high frequency of complicated obstetric anamnesis: the number of miscarriages, habitual miscarriage, births before 28 and before 32 weeks. Infectious processes in the genital system were observed with the same frequency. There were changes in the methods of correction: the frequency of pessary use increased from 38.2 to 49.3%, the frequency of surgical cerclage decreased from 56.9 to 1.4%, and the use of gestagens alone increased 10-fold from 4.9 to 49.3% (pp=0.116). There was a marked decrease in the incidence of chorioamnionitis from 4.5 to 0.7% (p=0.091) and a significant decrease in premature rupture of the fetal membranes (PRFE) from 46.4 to 20.7% (p<0.001), largely due to a decrease in the incidence of PRFE at gestational age up to 37 weeks. CONCLUSION The change in the management of pregnant women with ICI was manifested by a decrease in the use of cerclage with a simultaneous increase in the use of pessaries and gestagens alone. This made it possible to maintain the number of term deliveries, to reduce the frequency of chorioamnionitis by more than 4 times and PRPO, which was 2 times more associated with a decrease in the frequency of PRPO at gestational age up to 37 weeks.


  • Open Access

    Iron deficiency anemia in pregnant women

    by L. D. Belotserkovtseva, L. V. Kovalenko, V. N. Zinin, S. E. Ivannikov, М. Р. Кельдасова

    Introduction The problem of iron deficiency anemia (IDA), especially in pregnant women, continues to be relevant. Despite the achieved methods of diagnosis and treatment, the number of pregnant women with IDA continues to grow. Thus, according to WHO 2020 data, the prevalence of anemia among women of reproductive age ranged from 9.1 % in Australia to 69.6 % in Yemen.The aim of the work was to determination of the current state of the problem of IDA in pregnant women.Materials and methods Original articles, randomized clinical trials, and meta-analyses were reviewed in the Scopus database, PubMed and the eLibrary platform, using the key words “iron”, “oral”, “intravenous iron”, “intravenous iron therapy”, “pregnancy”, “anemia”, “treatment”, “randomized control trial”, “anemia in pregnancy”, “treatment of anemia in pregnancy”, “intravenous iron in pregnancy”, “IDA complications for mother and fetus”. The depth of the search was 5 years.Results and discussion There are different views on the classification and diagnosis of IDA in the guidelines of professional organizations. According to most guidelines hemoglobin and ferritin levels are the most reliable tests for the verification and prediction of IDA. Despite the fact that the peculiarities of the pathogenesis and approaches to the treatment of IDA have been studied, its prevalence among women remains very high. The reasons for this lie in inadequate diagnosis and incomplete therapy in terms of its duration and drugs selection. The methods of diagnosis and treatment of IDA are currently being actively studied and improved in anticipation of obtaining the greatest benefits.Conclusion Complications of IDA in the third trimester for newborns are the development of anemia, impaired development of the nervous system and cognitive disorders, which requires active prevention in the second trimester using, among other things, parenteral iron preparations.


  • SARS-COV-2 IS A NEW RISK FACTOR FOR PREECLAMPSIA

    by Л. Д. Белоцерковцева, Л. В. Коваленко, В. В. Панкратов, С. Е. Иванников, И. И. Мордовина, О. В. Козловская, А. М. Шумков, Д. М. Гаджиева

  • Preterm prelabour rupture of membranes before 34 weeks. Choosing a safe latency period

    by L.D. Belotserkovtseva, V.V. Pankratov, S.E. Ivannikov, I.I. Kilicheva, О.Yu. Purnov, А.е. Gilmanova, Surgut Surgut Clinical Perinatal Centre


  • Preterm labour. Which tocolytic to use during maternal transfer?

    by Surgut Surgut Clinical Perinatal Centre, L.D. Belotserkovtseva, L.V. Kovalenko, V.V. Pankratov, S.E. Ivannikov, S.A. Kravchenko